Home > News > Pharmaceutical industry looks to commercial metathesis 13th February 2007
February 13th, 2007
Pharmaceutical industry looks to commercial metathesis 13th February 2007
Abstract:
Commercially available metathesis catalysts could provide drugs manufacturers with new opportunities.
Olefin metathesis is one of the most versatile ways of making carbon-carbon bonds and the process has been exploited by petrochemical, polymer, and specialty chemical industries to process simple hydrocarbons for almost 50 years.
China is expected to drive the global nanotechnology and catalysts market this year, a new report claims. Research firm RNCOS predicts that nanoscience will gain huge investment over the next twenty years, bringing about radical changes in the pharmaceutical industry.
Source:
platinum.matthey.com
Bookmark:
Nanomedicine
How Gold Nanoparticles Can Help Fight Ovarian Cancer May 21st, 2013
MU Researchers Develop Radioactive Nanoparticles that Target Cancer Cells: This is an early step toward developing therapies for metastasized cancers, MU scientist says May 21st, 2013
Nanoparticle Delivers Large Protein Complex to Cancer Cell Nucleus May 20th, 2013
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals
International survey supports need for built-in water protection on smartphones and tablets May 21st, 2013
Rice unveils method for tailoring optical processors: Arranging nanoparticles in geometric patterns allows for control of light with light May 21st, 2013
Nanoparticle Harnesses Powerful Radiation Therapy for Cancer May 20th, 2013
Microneedle-Delivered Nanoparticles Boost Antitumor Vaccines May 20th, 2013